Inflammation and Neuronal Susceptibility to Excitotoxic Cell Death

  • João O. Malva
  • Liliana Bernardino

The fast growing research field of Neuroinflammation is challenging the traditional view of the Brain as an immune privileged organ. Our increasing understanding of the mechanisms involved in the close functional interaction between neurons and glia in health and disease is contributing to shed new light into the cellular and molecular mechanisms of neurodegeneration. The response of microglia and astrocytes to injury, releasing signaling molecules (specially, cytokines, chemokines, growth factors, reactive oxygen and nitrogen species), is central in neuroinflammation and in neuron death/survival.


Major Histocompatibility Complex Microglial Cell Receptor Interact Protein Central Nervous System Parenchyma Organotypic Hippocampal Slice Culture 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

8. References

  1. Adam-Klages, S., Adam, D., Wiegmann, K., Struve, S., Kolanus, W., Schneider-Mergener, J. and Kronke, M., 1996, FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86: 937.PubMedGoogle Scholar
  2. Adam-Klages, S., Schwandner, R., Adam, D., Kreder, D., Bernardo, K. and Kronke, M., 1998, Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor. J. Leukoc. Biol. 63: 678.PubMedGoogle Scholar
  3. Aggarwal, B.B., 2000, Tumour necrosis factors receptor associated signaling molecules and their role in activation of apoptosis, JNK and NF-kappaB. Ann. Rheum. Dis. 59(Suppl 1): 6.Google Scholar
  4. Aggarwal, B.B., 2003, Signaling pathways of the TNF superfamily: a double-edged sword. Nat. Ver. Immunol. 3: 745.Google Scholar
  5. Akira, S., Takeda, K. and Kaisho, T., 2001, Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2: 675.PubMedGoogle Scholar
  6. Allan, S.M. and Rothwell, N.J., 2001, Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2: 734.PubMedGoogle Scholar
  7. Allen, N.J. and Barres, B.A., 2005, Signaling between glia and neurons: focus on synaptic plasticity. Curr. Opin. Neurobiol. 15: 542.PubMedGoogle Scholar
  8. Aloisi, F., Ria, F. and Adorini, L., 2000, Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol. Today 21: 141.PubMedGoogle Scholar
  9. Aloisi, F., Ria, F., Penna, G. and Adorini, L., 1998, Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J. Immunol. 160: 4671.PubMedGoogle Scholar
  10. Alvarez-Maubecin, V., Garcia-Hernandez, F., Williams, J.T. and Van Bockstaele, E.J., 2000, Functional coupling between neurons and glia. J. Neurosci. 20: 4091.PubMedGoogle Scholar
  11. Ambrosini, E. and Aloisi, F., 2004, Chemokines and glial cells: a complex network in the central nervous system. Neurochem. Res. 29: 1017.PubMedGoogle Scholar
  12. Anderson, K.V., 2000, Toll signaling pathways in the innate immune response. Curr. Opin. Immunol. 12: 13.PubMedGoogle Scholar
  13. Anderson, K.V., Bokla, L. and Nusslein-Volhard, C., 1985, Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product. Cell 42: 791.PubMedGoogle Scholar
  14. Asensio, V.C. and Campbell, I.L., 1999, Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci. 22: 504.PubMedGoogle Scholar
  15. Baeuerle, P.A., 1998, Pro-inflammatory signaling: last pieces in the NF-kappaB puzzle? Curr. Biol. 8: R19.PubMedGoogle Scholar
  16. Baeuerle, P.A. and Baltimore, D., 1988, I kappa B: a specific inhibitor of the NF-kappaB transcription factor. Science 242: 540.PubMedGoogle Scholar
  17. Bailey, S.L., Carpentier, P.A., McMahon, E.J., Begolka, W.S. and Miller, S.D., 2006, Innate and adaptive immune responses of the central nervous system. Crit. Rev. Immunol. 26: 149.PubMedGoogle Scholar
  18. Bajetto, A., Bonavia, R., Barbero, S., Florio, T. and Schettini, G., 2001, Chemokines and their receptors in the central nervous system. Front. Neuroendocrinol. 22: 147.PubMedGoogle Scholar
  19. Bajetto, A., Bonavia, R., Barbero, S. and Schettini, G., 2002, Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J. Neurochem. 82: 1311.PubMedGoogle Scholar
  20. Balosso, S., Ravizza, T., Perego, C., Peschon, J., Campbell, I.L., De Simoni, M.G. and Vezzani, A., 2005, Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors. Ann. Neurol. 57: 804.PubMedGoogle Scholar
  21. Ban, E.M., 1994, Interleukin-1 receptors in the brain: characterization by quantitative in situ autoradiography. Immunomethods 5: 31.PubMedGoogle Scholar
  22. Barger, S.W., Horster, D., Furukawa, K., Goodman, Y., Krieglstein, J. and Mattson, M.P., 1995, Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc. Nat. Acad. Sci. USA 92: 9328.PubMedGoogle Scholar
  23. Barone, F.C., Arvin, B., White, R.F., Miller, A., Webb, C.L., Willette, R.N., Lysko, P.G and Feuerstein, G.Z., 1997, Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28: 1233.PubMedGoogle Scholar
  24. Batchelor, P.E., Liberatore, G.T., Wong, J.Y., Porritt, M.J., Frerichs, F., Donnan, G.A. and Howells, D.W., 1999, Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci. 19: 1708.PubMedGoogle Scholar
  25. Bauer, J., Bradl, M., Hickley, W.F., Forss-Petter, S., Breitschopf, H., Linington, C., Wekerle, H. and Lassmann, H., 1998, T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition. Am. J. Pathol. 153: 715.PubMedGoogle Scholar
  26. Beattie, M.S., Hermann, G.E., Rogers, R.C. and Bresnahan, J.C., 2002, Cell death in models of spinal cord injury. Prog. Brain Res. 137: 37.PubMedGoogle Scholar
  27. Becher, B., Prat, A. and Antel, J.P., 2000, Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia 29: 293.PubMedGoogle Scholar
  28. Belmadani, A., Tran, P.B., Ren, D. and Miller, R.J., 2006, Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J. Neurosci. 26: 3182.PubMedGoogle Scholar
  29. Belvin, M.P. and Anderson, K.V., 1996, A conserved signaling pathway: the Drosophila toll-dorsal pathway. Annu. Rev. Cell Dev. Biol. 12: 393.PubMedGoogle Scholar
  30. Benveniste, E.N., 1998, Cytokine actions in the central nervous system. Cytokine Growth Factor Rev. 9: 259.PubMedGoogle Scholar
  31. Bergles, D.E., Roberts, J.D., Somogyi, P., and Jahr, C.E., 2000, Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature 405: 187.PubMedGoogle Scholar
  32. Bernardino, L., Xapelli, S., Silva, A.P., Jakobsen, B., Poulsen, F.R., Oliveira, C.R., Vezzani, A., Malva, J.O. and Zimmer, J., 2005a, Modulator effects of Interleukin-1 beta and Tumor Necrosis Factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. J. Neurosci. 25: 6734.PubMedGoogle Scholar
  33. Bernardino, L., Ferreira, R., Cristóvão, A.J., Sales, F. and Malva, J.O., 2005b, Inflammation and neurogenesis in temporal lobe epilepsy. Curr. Drug Targets C.N.S. Neurol. Disord. 4: 349.Google Scholar
  34. Beutler, B. and van Huffel, C., 1994, Unravelling function in the TNF ligand and receptor families. Science 264: 667.PubMedGoogle Scholar
  35. Bezzi, P. and Volterra, A., 2001, A neuron-glia signaling network in the active brain. Curr. Opin. Neurobiol. 11: 387.PubMedGoogle Scholar
  36. Bezzi, P., Vesce, S., Panzarasa, P. and Volterra, A., 1999, Astrocytes as active participants of glutamatergic function and regulators of its homeostasis. Adv. Exp. Med. Biol. 468: 69.PubMedGoogle Scholar
  37. Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., De Clercq, E., Vescovi, A., Bagetta, G., Kollias, G., Meldolesi, J. and Volterra, A., 2001, CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4: 702.PubMedGoogle Scholar
  38. Biber, K., Zuurman, M.W., Dijkstra, I.M. and Boddeke, H.W., 2002, Chemokines in the brain: neuroimmunology and beyond. Curr. Opin. Pharmacol. 2: 63.PubMedGoogle Scholar
  39. Biber, K., de Jong, E.K., van Weering, H.R. and Boddeke, H.W., 2006, Chemokines and their receptors in central nervous system disease. Curr. Drug Targets 7: 29.PubMedGoogle Scholar
  40. Blonska, M., Shambharkar, P.B., Kobayashi, M., Zhang, D., Sakurai, H., Su, B. and Lin, X., 2005, TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappaB activation. J. Biol. Chem. 280: 43056.PubMedGoogle Scholar
  41. Bonde, C., Noraberg, J., Noer, H. and Zimmer, J., 2005, Ionotropic glutamate receptors and glutamate transporters are involved in necrotic neuronal cell death induced by oxygen-glucose deprivation of hippocampal slice cultures. Neuroscience 136: 779.PubMedGoogle Scholar
  42. Boucsein, C., Zacharias, R., Farber, K., Pavlovic, S., Hanisch, U.K. and Kettenmann, H., 2003, Purinergic receptors on microglial cells: functional expression in acute brain slices and modulation of microglial activation in vitro. Eur. J. Neurosci. 17: 2267.PubMedGoogle Scholar
  43. Brough, D., Le Feuvre, R.A., Iwakura, Y. and Rothwell, N.J., 2002, Purinergic (P2X7) receptor activation of microglia induces cell death via an interleukin-1-independent mechanism. Mol. Cell Neurosci. 19: 272.PubMedGoogle Scholar
  44. Burns, K., Clatworthy, J., Martin, L., Martinon, F., Plumpton, C., Maschera, B., Lewis, A., Ray, K., Tschopp, J. and Volpe, F., 2000, Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat. Cell Biol. 2: 346.PubMedGoogle Scholar
  45. Burudi, E.M. and Regnier-Vigouroux, A., 2001, Regional and cellular expression of the mannose receptor in the post-natal developing mouse brain. Cell Tissue Res. 303: 307.PubMedGoogle Scholar
  46. Campbell, I.L., 2005, Cytokine-mediated inflammation, tumorigenesis, and disease-associated JAK/STAT/SOCS signaling circuits in the CNS. Brain Res. Brain Res. Rev. 48: 166.PubMedGoogle Scholar
  47. Cao, Z., Henzel, W.J. and Gao, X., 1996a, IRAK: a kinase associated with the interleukin-1 receptor. Science 271: 1128.PubMedGoogle Scholar
  48. Cao, Z., Xiong, J., Takeuchi, M., Kurama, T. and Goeddel, D.V., 1996b, TRAF6 is a signal transducer for interleukin-1. Nature 383: 443.PubMedGoogle Scholar
  49. Cartier, L., Hartley, O., Dubois-Dauphin, M. and Krause K.H., 2005, Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res. Brain Res. Rev. 48: 16.PubMedGoogle Scholar
  50. Chan, F.K., 2000, The pre-ligand binding assembly domain: a potential target of inhibition of tumour necrosis factor receptor function. Ann. Rheum. Dis. 59(Suppl. 1): 50.Google Scholar
  51. Chan, F.K., Chun, H.J., Zheng, L., Siegel, R.M., Bui, K.L. and Lenardo, M.J., 2000, A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288: 2351.PubMedGoogle Scholar
  52. Chavarria A. and Alcocer-Varela J., 2004, Is damage in central nervous system due to inflammation? Autoimmun. Rev. 3: 251.PubMedGoogle Scholar
  53. Chen, G. and Goeddel, D.V., 2002, TNF-R1 signaling: a beautiful pathway. Science 296: 1634.PubMedGoogle Scholar
  54. Chen, Y. and Swanson, R.A., 2003, Astrocytes and brain injury. J. Cereb. Blood Flow. Metab. 23: 137.PubMedGoogle Scholar
  55. Cheng, B., Christakos, S. and Mattson, M.P., 1994, Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12: 139.PubMedGoogle Scholar
  56. Chinnaiyan, A.M., O’Rourke, K., Tewari, M. and Dixit, V.M., 1995, FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505.PubMedGoogle Scholar
  57. Choi, D.W., 1992, Excitotoxic cell death. J. Neurobiol. 23: 1261.PubMedGoogle Scholar
  58. Colombaioni, L. and Garcia-Gil, M., 2004, Sphingolipid metabolites in neural signaling and functions. Brain Res. Rev. 46: 328.PubMedGoogle Scholar
  59. Colotta, F., Re, F., Muzio, M., Bertini, R., Polentarutti, N., Sironi, M., Giri, J.G., Dower, S.K., Sims, J.E. and Mantovani, A., 1993, Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261: 472.PubMedGoogle Scholar
  60. Couraud, P.O., 1994, Interactions between lymphocytes, macrophages, and central nervous system cells. J. Leukoc. Biol. 56: 407.PubMedGoogle Scholar
  61. Croston, G.E., Cao, Z. and Goeddel, D.V., 1995, NF-kappa B activation by interleukin-1 (IL-1) requires an IL-1 receptor-associated protein kinase activity. J. Biol. Chem. 270: 16514.PubMedGoogle Scholar
  62. Cunha, R.A. and Ribeiro, J.A., 2000, ATP as a presynaptic modulator. Life Sci. 68: 119.PubMedGoogle Scholar
  63. Cunningham, C., Wilcockson, D.C., Campion, S., Lunnon, K. and Perry, V.H., 2005, Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 25: 9275.PubMedGoogle Scholar
  64. Dauphinee, S.M. and Karsan, A., 2006, Lipopolysaccharide signaling in endothelial cells. Lab. Invest. 86: 9.PubMedGoogle Scholar
  65. Davies, C.A., Loddick, S.A., Toulmond, S., Stroemer, R.P., Hunt, J. and Rothwell, N.J., 1999, The progression and topographic distribution of interleukin-1beta expression after permanent middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 19: 87.PubMedGoogle Scholar
  66. Davis, C.N., Mann, E., Behrens, M.M., Gaidarova, S., Rebek, M., Rebek, J. Jr. and Bartfai, T., 2006, MyD88-dependent and -independent signaling by IL-1 in neurons probed by bifunctional Toll/IL-1 receptor domain/BB-loop mimetics. Proc. Natl. Acad. Sci. USA 103: 2953.PubMedGoogle Scholar
  67. Delhase, M., Hayakawa, M., Chen, Y. and Karin, M., 1999, Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284: 309.PubMedGoogle Scholar
  68. Dempsey, P.W., Doyle, S.E., He, J.Q. and Cheng, G., 2003, The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev. 14: 193.PubMedGoogle Scholar
  69. Denecker, G., Vercammen, D., Declercq, W. and Vandenabeele, P., 2001, Apoptotic and necrotic cell death induced by death domain receptors. Cell. Mol. Life Sci. 58: 356.PubMedGoogle Scholar
  70. Devalaraja, M.N. and Richmond, A., 1999, Multiple chemotactic factors: fine control or redundancy? Trends Pharmacol. Sci. 20: 151.PubMedGoogle Scholar
  71. Devitt, A., Moffatt, O.D., Raykundalia, C., Capra, J.D., Simmons, D.L. and Gregory, C.D., 1998, Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392: 505.PubMedGoogle Scholar
  72. Di Virgilio, F., Sanz, J.M., Chiozzi, P. and Falzoni, S., 1999, The P2Z/P2X7 receptor of microglial cells: a novel immunomodulatory receptor. Prog. Brain Res. 120: 355.PubMedGoogle Scholar
  73. DiDonato, J.A., Hayakawa, M., Rothwarf, D.M., Zandi, E. and Karin, M., 1997, A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388: 548.PubMedGoogle Scholar
  74. Dinarello, C.A., 1996, Biologic basis for interleukin-1 in disease. Blood 87: 2095.PubMedGoogle Scholar
  75. Dobrogowska, D.H., Lossinsky, A.S., Tarnawski, M. and Vorbrodt, A.W., 1998, Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. J. Neurocytol. 27: 163.PubMedGoogle Scholar
  76. Dong, Y. and Benveniste, E.N., 2001, Immune function of astrocytes. Glia 36:180.PubMedGoogle Scholar
  77. Dubyak, G.R. and el-Moatassim, C., 1993, Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol. 265: C577.PubMedGoogle Scholar
  78. Dunne, A. and O’Neill, L.A., 2003, The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense, Sci. STKE. 171: re3.Google Scholar
  79. Elward, K. and Gasque, P., 2003, “Eat me” and “don’t eat me” signals govern the innate immune response and tissue repair in the CNS: emphasis on the critical role of the complement system. Mol. Immunol. 40: 85.Google Scholar
  80. Engelhardt, B., 2006, Molecular mechanisms involved in T cell migration across the blood-brain barrier. J. Neural. Transm. 113: 477.PubMedGoogle Scholar
  81. Eriksson, C., Winblad, B. and Schultzberg, M., 1998, Kainic acid induced expression of interleukin-1 receptor antagonist mRNA in the rat brain. Brain Res. Mol. Brain Res. 58: 195.PubMedGoogle Scholar
  82. Eriksson, C., Tehranian, R., Iverfeldt, K., Winblad, B. and Schultzberg, M., 2000, Increased expression of mRNA encoding interleukin-1beta and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration. J. Neurosci. Res. 60: 266.PubMedGoogle Scholar
  83. Fernandez, E.J. and Lolis, E., 2002, Structure, function, and inhibition of chemokines. Annu. Rev. Pharmacol. Toxicol. 42: 469.PubMedGoogle Scholar
  84. Ferrari, D., Villalba, M., Chiozzi, P., Falzoni, S., Ricciardi-Castagnoli, P. and Di Virgilio, F., 1996, Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J. Immunol. 156: 1531.PubMedGoogle Scholar
  85. Ferrari, D., Chiozzi, P., Falzoni, S., Hanau, S. and Di Virgilio, F., 1997a, Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185: 579.PubMedGoogle Scholar
  86. Ferrari, D., Wesselborg, S., Bauer, M.K. and Schulze-Osthoff, K., 1997b, Extracellular ATP activates transcription factor NF-kappaB through the P2Z purinoreceptor by selectively targeting NF-kappaB p65. J. Cell Biol. 139: 1635.PubMedGoogle Scholar
  87. Ferrari, D., Los, M., Bauer, M.K., Vandenabeele, P., Wesselborg, S. and Schulze-Osthoff, K., 1999, P2z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett. 447: 71.PubMedGoogle Scholar
  88. Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R.M., Curti, A., Idzko, M., Panther, E. and Di Virgilio, F., 2006, The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol. 176: 3877.PubMedGoogle Scholar
  89. Fink, K.B., Andrews, L.J., Butler, W.E., Ona, V.O., Li, M., Bogdanov, M., Endres, M., Khan, S.Q., Namura, S., Stieg, P.E., Beal, M.F., Moskowitz, M.A., Yuan, J. and Friedlander, R.M., 1999, Reduction of post-traumatic brain injury and free radical production by inhibition of the caspase-1 cascade. Neuroscience 94: 1213.PubMedGoogle Scholar
  90. Flügel, A., Schwaiger, F.W., Neumann, H., Medana, I., Willem, M., Wekerle, H., Kreutzberg, G.W. and Graeber, M.B., 2000, Neuronal FasL induces cell death of encephalitogenic T lymphocytes. Brain Pathol. 10: 353.PubMedGoogle Scholar
  91. Flügel, A., Berkowicz, T., Ritter, T., Labeur, M., Jenne, D.E., Li, Z., Ellwart, J.W., Willem, M., Lassmann, H. and Wekerle, H., 2001, Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14: 547.PubMedGoogle Scholar
  92. Fontaine, V., Mohand-Said, S., Hanoteau, N., Fuchs, C., Pfizenmaier, K. and Eisel, U., 2002, Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J. Neurosci. 22: RC216.Google Scholar
  93. Frei, K., Lins, H., Schwerdel, C. and Fontana, A., 1994, Antigen presentation in the central nervous system. The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. J. Immunol. 152: 2720.PubMedGoogle Scholar
  94. Friedman, W.J., 2001, Cytokines regulate expression of the type 1 interleukin-1 receptor in rat hippocampal neurons and glia. Exp. Neurol. 168: 23.PubMedGoogle Scholar
  95. Friedman, W.J., 2005, Interactions of interleukin-1 with neurotrophic factors in the central nervous system: beneficial or detrimental? Mol. Neurobiol. 32: 133.PubMedGoogle Scholar
  96. Furukawa, K. and Mattson, M.P., 1998, The transcription factor NF-kappaB mediates increases in calcium currents and decreases in NMDA- and AMPA/kainate-induced currents induced by tumor necrosis factor-alpha in hippocampal neurons. J. Neurochem. 70: 1876.PubMedGoogle Scholar
  97. Galasso, J.M., Harrison, J.K. and Silverstein, F.S., 1998, Excitotoxic brain injury stimulates expression of the chemokine receptor CCR5 in neonatal rats. Am. J. Pathol. 153: 1631.PubMedGoogle Scholar
  98. Galasso, J.M., Miller, M.J., Cowell, R.M., Harrison, J.K., Warren, J.S. and Silverstein, FS., 2000, Acute excitotoxic injury induces expression of monocyte chemoattractant protein-1 and its receptor, CCR2, in neonatal rat brain. Exp. Neurol., 165: 295.PubMedGoogle Scholar
  99. Gay, N.J. and Keith, F.J., 1991, Drosophila Toll and IL-1 receptor. Nature 351: 355.PubMedGoogle Scholar
  100. Ghosh, S. and Karin, M., 2002, Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl): 81.Google Scholar
  101. Gourmala, N.G., Limonta, S., Bochelen, D., Sauter, A. and Boddeke, H.W., 1999, Localization of macrophage inflammatory protein: macrophage inflammatory protein-1 expression in rat brain after peripheral administration of lipopolysaccharide and focal cerebral ischemia. Neuroscience 88: 1255.PubMedGoogle Scholar
  102. Greenfeder, S.A., Nunes, P., Kwee, L., Labow, M., Chizzonite, R.A. and Ju, G., 1995, Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 270: 13757.PubMedGoogle Scholar
  103. Grell, M., Zimmermann, G., Hulser, D., Pfizenmaier, K. and Scheurich, P., 1994, TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways. J. Immunol. 153: 1963.PubMedGoogle Scholar
  104. Grell, M., Douni, E., Wajant, H., Lohden, M., Clauss, M., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G., Pfizenmaier, K. and Scheurich, P., 1995, The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83: 793.PubMedGoogle Scholar
  105. Griffin, W.S., Liu, L., Li, Y., Mrak, R.E. and Barger, S.W., 2006, Interleukin-1 mediates Alzheimer and Lewy body pathologies. J. Neuroinflammation 3: 5.PubMedGoogle Scholar
  106. Gruol, D.L. and Nelson, T.E., 2005, Purkinje neuron physiology is altered by the inflammatory factor interleukin-6. Cerebellum 4: 198.PubMedGoogle Scholar
  107. Hanisch, U.K., 2002, Microglia as a source and target of cytokines. Glia 40: 140.PubMedGoogle Scholar
  108. Hatten, M.E., Liem, R.K., Shelanski, M.L. and Mason, C.A., 1991, Astroglia in CNS injury. Glia 4: 233.PubMedGoogle Scholar
  109. Hehlgans, T. and Mannel, D.N., 2002, The TNF-TNF receptor system. Biol. Chem. 383: 1581.PubMedGoogle Scholar
  110. Hellstrom, I.C., Danik, M., Luheshi, G.N. and Williams, S., 2005, Chronic LPS exposure produces changes in intrinsic membrane properties and a sustained IL-beta-dependent increase in GABAergic inhibition in hippocampal CA1 pyramidal neurons. Hippocampus 15: 656.PubMedGoogle Scholar
  111. Heppner, F.L., Skutella, T., Hailer, N.P., Haas, D. and Nitsch, R., 1998, Activated microglial cells migrate towards sites of excitotoxic neuronal injury inside organotypic hippocampal slice cultures. Eur. J. Neurosci. 10: 3284.PubMedGoogle Scholar
  112. Hermann, G.E., Rogers, R.C., Bresnahan, J.C. and Beattie, M.S., 2001, Tumor necrosis factor-alpha induces cFOS and strongly potentiates glutamate-mediated cell death in the rat spinal cord. Neurobiol. Dis. 8: 590.PubMedGoogle Scholar
  113. Herx, L.M., Rivest, S. and Yong, V.W., 2000, Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor. J. Immunol. 165: 2232.PubMedGoogle Scholar
  114. Hickey, W.F., 2001, Basic principles of immunological surveillance of the normal central nervous system. Glia 36: 118.PubMedGoogle Scholar
  115. Hickey, W.F. and Kimura, H., 1988, Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239: 290.PubMedGoogle Scholar
  116. Hide, I., Tanaka, M., Inoue, A., Nakajima, K., Kohsaka, S., Inoue, K. and Nakata, Y., 2000, Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia. J. Neurochem. 75: 965.PubMedGoogle Scholar
  117. Higuchi, M. and Aggarwal, B.B., 1994, TNF induces internalization of the p60 receptor and shedding of the p80 receptor. J. Immunol. 152: 3550.PubMedGoogle Scholar
  118. Hofmeister, R., Wiegmann, K., Korherr, C., Bernardo, K., Kronke, M. and Falk, W., 1997, Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein. J. Biol. Chem. 272: 27730.PubMedGoogle Scholar
  119. Honda, S., Sasaki, Y., Ohsawa, K., Imai, Y., Nakamura, Y., Inoue, K. and Kohsaka, S., 2001, Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J. Neurosci. 21: 1975.PubMedGoogle Scholar
  120. Houzen, H., Kikuchi, S., Kanno, M., Shinpo K. and Tashiro, K., 1997, Tumor necrosis factor enhancement of transient outward potassium currents in cultured rat cortical neurons. J. Neurosci. Res. 50: 990.PubMedGoogle Scholar
  121. Hsu, H., Xiong, J. and Goeddel, D.V., 1995, The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81: 495.PubMedGoogle Scholar
  122. Hsu, H., Huang, J., Shu, H.B., Baichwal, V. and Goeddel, D.V., 1996a, TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4: 387.PubMedGoogle Scholar
  123. Hsu, H., Shu, H.B., Pan, M.G. and Goeddel, D.V., 1996b, TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84: 299.PubMedGoogle Scholar
  124. Hu, S., Sheng, W.S., Ehrlich, L.C., Peterson, P.K. and Chao, C.C., 2000, Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 7: 153.PubMedGoogle Scholar
  125. Huber, J.D., Egleton, R.D. and Davis, T.P., 2001, Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 24: 719.PubMedGoogle Scholar
  126. Idriss, H.T. and Naismith, J.H., 2000, TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc. Res. Tech. 50: 184.PubMedGoogle Scholar
  127. Imitola, J., Raddassi, K., Park, K.I., Mueller, F.J., Nieto, M., Teng, Y.D., Frenkel, D., Li, J., Sidman, R.L., Walsh, C.A., Snyder, E.Y. and Khoury, S.J., 2004, Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc. Natl. Acad. Sci. USA 101: 18117.PubMedGoogle Scholar
  128. Inoue, K., 2002, Microglial activation by purines and pyrimidines. Glia 40: 156.PubMedGoogle Scholar
  129. Itoh, N. and Nagata, S., 1993, A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 268: 10932.PubMedGoogle Scholar
  130. James, G. and Butt, M., 2002, P2Y and P2X purinoceptor mediated Ca2+ signaling in glial cell pathology in the central nervous system. Eur. J. Pharmacol. 447: 247.PubMedGoogle Scholar
  131. Jiang, Y., Woronicz, J.D., Liu, W. and Goeddel, D.V., 1999, Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 283: 543.PubMedGoogle Scholar
  132. Jones, E.Y., 2000, The tumour necrosis factor receptor family: life or death choices. Curr. Opin. Struct. Biol. 10: 644.PubMedGoogle Scholar
  133. Kaisho T. and Akira S., 2000, Critical roles of Toll-like receptors in host defense. Crit. Ver. Immunol. 20: 393.Google Scholar
  134. Karin, M. and Lin, A., 2002, NF-kappaB at the crossroads of life and death. Nat. Immunol. 3: 221.PubMedGoogle Scholar
  135. Karkkainen, I., Rybnikova, E., Pelto-Huikko, M. and Huovila, A.P., 2000, Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS. Mol. Cell Neurosci. 15: 547.PubMedGoogle Scholar
  136. Kawai, T., Adachi, O., Ogawa, T., Takeda, K. and Akira, S., 1999, Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115.PubMedGoogle Scholar
  137. Kelliher, M.A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B.Z. and Leder, P., 1998, The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8: 297.PubMedGoogle Scholar
  138. Kielian, T., Mayes, P. and Kielian, M., 2002, Characterization of microglial responses to Staphylococcus aureus: effects on cytokine, costimulatory molecule, and Toll-like receptor expression. J. Neuroimmunol. 130: 86.PubMedGoogle Scholar
  139. Kim, S.U. and de Vellis, J., 2005, Microglia in health and disease. J. Neurosci. Res. 81: 302.PubMedGoogle Scholar
  140. Kischkel, F.C., Lawrence, D.A., Chuntharapai, A., Schow, P., Kim, K.J. and Ashkenazi, A., 2000, Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12: 611.PubMedGoogle Scholar
  141. Kishida, S., Sanjo, H., Akira, S., Matsumoto, K. and Ninomiya-Tsuji, J., 2005, TAK-1 binding protein 2 facilitates ubiquitination of TRAF6 and assembly of TRAF6 with IKK in the signaling pathway. Genes Cell 10: 447.Google Scholar
  142. Kitchens, R.L., Thompson, P.A., O’Keefe, G.E. and Munford, R.S., 2000, Plasma constituents regulate LPS binding to, and release from, the monocyte cell surface. J. Endotoxin Res. 6: 477.PubMedGoogle Scholar
  143. Knopf, P.M., Harling-Berg, C.J., Cserr, H.F., Basu, D., Sirulnick, E.J., Nolan, S.C., Park, J.T., Keir, G., Thompson, E.J. and Hickey, W.F., 1998, Antigen-dependent intrathecal antibody synthesis in the normal rat brain: tissue entry and local retention of antigen-specific B cells. J. Immunol. 161: 692.PubMedGoogle Scholar
  144. Kolesnick, R.N. and Kronke, M., 1998, Regulation of ceramide production and apoptosis. Annu. Rev. Physiol. 60: 643.PubMedGoogle Scholar
  145. Kreutzberg, G.W., 1996, Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19: 312.PubMedGoogle Scholar
  146. Kriegler, M., Perez, C., DeFay, K., Albert, I. and Lu, S.D., 1988, A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53: 45.PubMedGoogle Scholar
  147. Kristensen, B.W., Noraberg, J. and Zimmer, J., 2001, Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures. Brain Res. 917: 21.PubMedGoogle Scholar
  148. Laflamme, N. and Rivest, S., 2001, Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J. 15: 155.PubMedGoogle Scholar
  149. Lai, A.Y., Swayze, R.D., El-Husseini, A. and Song, C., 2006, Interleukin-1 beta modulates AMPA receptor expression and phosphorylation in hippocampal neurons. J. Neuroimmunol. 175: 97.PubMedGoogle Scholar
  150. Lassmann, H., Schmied, M., Vass, K. and Hickey, W.F., 1993, Bone marrow derived elements and resident microglia in brain inflammation. Glia 7: 19.PubMedGoogle Scholar
  151. Le Feuvre, R.A., Brough, D., Iwakura, Y., Takeda, K. and Rothwell, N.J., 2002, Priming of macrophages with lipopolysaccharide potentiates P2X7-mediated cell death via a caspase-1-dependent mechanism, independently of cytokine production. J. Biol. Chem. 277: 3210.PubMedGoogle Scholar
  152. Legler, D.F., Micheau, O., Doucey, M.A., Tschopp, J. and Bron, C., 2003, Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity 18: 655.PubMedGoogle Scholar
  153. Lehnardt, S., Massillon, L., Follett, P., Jensen, F.E., Ratan, R., Rosenberg, P.A., Volpe, J.J. and Vartanian, T., 2003, Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. USA 100: 8514.PubMedGoogle Scholar
  154. Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.M. and Hoffmann, J.A., 1996, The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86: 973.PubMedGoogle Scholar
  155. Li, X. and Qin, J., 2005, Modulation of Toll-interleukin 1 receptor mediated signaling. J. Mol. Med. 83: 258.PubMedGoogle Scholar
  156. Li, X., Yang, Y. and Ashwell, J.D., 2002, TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416: 345.PubMedGoogle Scholar
  157. Li, C., Zienkiewicz, J. and Hawiger, J., 2005, Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway. J. Biol. Chem. 280: 26152.PubMedGoogle Scholar
  158. Ling, L., Cao, Z. and Goeddel, D.V., 1998, NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176. Proc. Natl. Acad. Sci. USA 95: 3792.PubMedGoogle Scholar
  159. Liu, Z.G., Hsu, H., Goeddel, D.V. and Karin, M., 1996, Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87: 565.PubMedGoogle Scholar
  160. Locksley, R.M., Killeen, N. and Lenardo, M.J., 2001, The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104: 487.PubMedGoogle Scholar
  161. Loddick, S.A., Liu, C., Takao, T., Hashimoto, K. and De Souza, E.B., 1998, Interleukin-1 receptors: cloning studies and role in central nervous system disorders. Brain Res. Brain Res. Rev. 26: 306.PubMedGoogle Scholar
  162. Lu, K.T., Wang, Y.W., Wo, Y.Y. and Yang, Y.L., 2005, Extracellular signal-regulated kinase-mediated IL-1-induced cortical neuron damage during traumatic brain injury. Neurosci. Lett. 386: 40.PubMedGoogle Scholar
  163. Lucas, S.M., Rothwell, N.J. and Gibson, R.M., 2006, The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147: S232.PubMedGoogle Scholar
  164. Luk, W.P., Zhang, Y., White, T.D., Lue, F.A., Wu, C., Jiang, C.G., Zhang, L. and Moldofsky, H., 1999, Adenosine: a mediator of interleukin-1beta-induced hippocampal synaptic inhibition. J. Neurosci. 19: 4238.PubMedGoogle Scholar
  165. Ma, Q., Jones, D., Borghesani, P.R., Segal, R.A., Nagasawa, T., Kishimoto, T., Bronson, R.T. and Springer, T.A., 1998, Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. USA 95: 9448.PubMedGoogle Scholar
  166. MacEwan, D.J., 2002, TNF receptor subtype signaling: differences and cellular consequences. Cell Signal 14: 477.PubMedGoogle Scholar
  167. Mackay, C.R., 2001, Chemokines: immunology’s high impact factors. Nat. Immunol. 2: 95.PubMedGoogle Scholar
  168. Mahad, D., Callahan, M.K., Williams, K.A., Ubogu, E.E., Kivisakk, P., Tucky, B., Kidd, G., Kingsbury, G.A., Chang, A., Fox, R.J., Mack, M., Sniderman, M.B., Ravid, R., Staugaitis, S.M., Stins, M.F. and Ransohoff, R.M., 2006, Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis. Brain 129: 212.PubMedGoogle Scholar
  169. Malagarie-Cazenave, S., Andrieu-Abadie, N., Sgui, B., Gouaz, V., Tardy, C., Cuvillier, O. and Levade, T., 2002, Sphingolipid signaling: molecular basis and role in TNF-induced cell death. Exp. Rev. Mol. Med. 515: 20.Google Scholar
  170. Malinin, N.L., Boldin, M.P., Kovalenko, A.V. and Wallach, D., 1997, MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 385: 540.PubMedGoogle Scholar
  171. Man, S.M., Ma, Y.R., Shang, D.S., Zhao, W.D., Li B., Guo, D.W., Fang, W.G., Zhu, L. and Chen, Y.H., 2006, Peripheral T cells overexpress MIP-1alpha to enhance its transendothelial migration in Alzheimer's disease. Neurobiol. Aging [Epub ahead of print].Google Scholar
  172. Mantovani, A., 1999, The chemokine system: redundancy for robust outputs. Immunol. Today 20: 254.PubMedGoogle Scholar
  173. Marchetti, L., Klein, M., Schlett, K., Pfizenmaier, K. and Eisel, U.L., 2004, Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J. Biol. Chem. 30: 32869.Google Scholar
  174. Mark, K.S. and Miller, D.W., 1999, Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-alpha exposure. Life Sci. 64: 1941.PubMedGoogle Scholar
  175. Mason, J.L., Suzuki, K., Chaplin, D.D. and Matsushima, G.K., 2001, Interleukin-1beta promotes repair of the CNS. J. Neurosci. 21: 7046.PubMedGoogle Scholar
  176. Mattson, M.P., Cheng, B., Baldwin, S.A., Smith-Swintosky, V.L., Keller, J., Geddes, J.W., Scheff, S.W. and Christakos, S., 1995, Brain injury and tumor necrosis factors induce calbindin D28k in astrocytes: evidence for a cytoprotective response. J. Neurosci. Res. 42: 357.PubMedGoogle Scholar
  177. McCluskey, L.P. and Lampson, L.A., 2000, Local neurochemicals and site-specific immune regulation in the CNS. J. Neuropathol. Exp. Neurol. 59: 177.PubMedGoogle Scholar
  178. Medzhitov, R. and Janeway, C.A. Jr., 1997, Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 9: 4.PubMedGoogle Scholar
  179. Medzhitov, R. and Janeway, C. Jr., 2000, Innate immune recognition: mechanisms and pathways. Immunol. Rev. 173: 89.PubMedGoogle Scholar
  180. Meffert, M.K. and Baltimore, D., 2005, Physiological functions for brain NF-kappaB. Trends Neurosci. 28: 37.PubMedGoogle Scholar
  181. Mennicken, F., Maki, R., de Souza, E.B. and Quirion, R., 1999, Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol. Sci. 20: 73.PubMedGoogle Scholar
  182. Mercurio, F., Zhu, H., Murray, B.W., Shevchenko, A., Bennett, B.L., Li, J., Young, D.B., Barbosa, M., Mann, M., Manning, A. and Rao, A., 1997, IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278: 860.PubMedGoogle Scholar
  183. Miller, L.G., Galpern, W.R., Dunlap, K., Dinarello, C.A. and Turner, T.J., 1991, Interleukin-1 augments gamma-aminobutyric acid A receptor function in brain. Mol. Pharmacol. 39: 105.PubMedGoogle Scholar
  184. Minagar, A., Jy, W., Jimenez, J.J. and Alexander, J.S., 2006, Multiple sclerosis as a vascular disease. Neurol. Res. 28: 230.PubMedGoogle Scholar
  185. Minami, M. and Satoh, M., 2003, Chemokines and their receptors in the brain: pathophysiological roles in ischemic brain injury, Life Sci. 74: 321.PubMedGoogle Scholar
  186. Minami, M. and Satoh, M., 2005, Role of chemokines in ischemic neuronal stress. Neuromolecular Med. 7: 149.PubMedGoogle Scholar
  187. Minami, M., Kuraishi, Y., Yamaguchi, T., Nakai, S., Hirai, Y. and Satoh, M., 1990, Convulsants induce interleukin-1 beta messenger RNA in rat brain. Biochem. Biophys. Res. Commun. 171: 832.PubMedGoogle Scholar
  188. Minami, M., Kuraishi, Y. and Satoh, M., 1991, Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain. Biochem. Biophys. Res. Commun. 176: 593.PubMedGoogle Scholar
  189. Miyachi, T., Asai, K., Tsuiki, H., Mizuno, H., Yamamoto, N., Yokoi, T., Aoyama, M., Togari, H., Wada, Y., Miura, Y. and Kato, T., 2001, Interleukin-1beta induces the expression of lipocortin 1 mRNA in cultured rat cortical astrocytes. Neurosci. Res. 40: 53.PubMedGoogle Scholar
  190. Monje, M.L., Toda, H. and Palmer, T.D., 2003, Inflammatory blockade restores adult hippocampal neurogenesis. Science 302: 1760.PubMedGoogle Scholar
  191. Moynagh, P.N., 2005, The interleukin-1 signaling pathway in astrocytes: a key contributor to inflammation in the brain. J. Anat. 207: 265.PubMedGoogle Scholar
  192. Moynagh, P.N., Williams, D.C., and O’Neill, L.A., 1994, Activation of NF-kappa B and induction of vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression in human glial cells by IL-1. Modulation by antioxidants. J. Immunol. 153: 2681.PubMedGoogle Scholar
  193. Murakami, Y., Okada, S. and Yokotani, K., 2002, Brain inducible nitric oxide synthase is involved in interleukin-1beta-induced activation of the central sympathetic outflow in rats. Eur. J. Pharmacol. 455: 73.PubMedGoogle Scholar
  194. Murdoch, C. and Finn, A., 2000, Chemokine receptors and their role in inflammation and infectious diseases. Blood 95: 3032.PubMedGoogle Scholar
  195. Murphy, P.M., Baggiolini, M., Charo, I.F., Hebert, C.A., Horuk, R., Matsushima, K., Miller, L.H., Oppenheim, J.J. and Power, C.A., 2000, International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52: 145.PubMedGoogle Scholar
  196. Nakajima, K. and Kohsaka, S., 2004, Microglia: neuroprotective and neurotrophic cells in the central nervous system. Curr. Drug Targets Cardiovasc. Haematol. Disord. 4: 65.PubMedGoogle Scholar
  197. Nedergaard, M., 1994, Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science 263: 1768.PubMedGoogle Scholar
  198. Neumann, H., 2001, Control of glial immune function by neurons. Glia 36: 191.PubMedGoogle Scholar
  199. Neumann, H., 2004, Inflammation, Neuroprotection. Models, Mechanisms and Therapies. Mathias Bahr, ed., Wiley-VGH, pp. 173-190.Google Scholar
  200. Neumann, H. and Wekerle, H., 1998, Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration. J. Neuropathol. Exp. Neurol. 57: 1.PubMedGoogle Scholar
  201. Neumann, H., Boucraut, J., Hahnel, C., Misgeld, T. and Wekerle, H., 1996, Neuronal control of MHC class II inducibility in rat astrocytes and microglia. Eur. J. Neurosci. 8: 2582.PubMedGoogle Scholar
  202. Neumann, H., Schmidt, H., Wilharm, E., Behrens, L. and Wekerle, H., 1997, Interferon gamma gene expression in sensory neurons: evidence for autocrine gene regulation. J. Exp. Med. 186: 2023.PubMedGoogle Scholar
  203. Neumann, H., Misgeld, T., Matsumuro, K. and Wekerle, H., 1998, Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor. Proc. Natl. Acad. Sci. USA 95: 5779.PubMedGoogle Scholar
  204. Neumeyer, J., Hallas, C., Merkel, O., Winoto-Morbach, S., Jakob, M., Thon, L., Adam, D., Schneider-Brachert, W. and Schutze, S., 2006, TNF-receptor I defective in internalization allows for cell death through activation of neutral sphingomyelinase. Exp. Cell Res. [Epub ahead of print].Google Scholar
  205. Nguyen, M.D., Julien, J.P. and Rivest, S., 2002, Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat. Rev. Neurosci. 3: 216.PubMedGoogle Scholar
  206. Noda, M., Nakanishi, H., Nabekura, J. and Akaike, N., 2000, AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. J. Neurosci. 20: 251.PubMedGoogle Scholar
  207. Ogoshi, F., Yin, H.Z., Kuppumbatti, Y., Song, B., Amindari, S. and Weiss, J.H., 2005, Tumor necrosis-factor-alpha (TNF-alpha) induces rapid insertion of Ca2+-permeable alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA)/kainate (Ca-A/K) channels in a subset of hippocampal pyramidal neurons. Exp. Neurol. 193: 384.PubMedGoogle Scholar
  208. O’Keefe, G.M., Nguyen, V.T. and Benveniste, E.N., 1999, Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF-beta, IL-4, IL-13 and IL-10. Eur. J. Immunol. 29: 1275.PubMedGoogle Scholar
  209. Olson, J.K. and Miller, S.D., 2004, Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173: 3916.PubMedGoogle Scholar
  210. O’Neill, L.A., 2002, Signal transduction pathways activated by the IL-1 receptor/Toll-like receptor superfamily. Curr. Top. Microbiol. Immunol. 270: 47.PubMedGoogle Scholar
  211. O’Neill, L.A. and Greene, C., 1998, Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J. Leukoc. Biol. 63: 650.PubMedGoogle Scholar
  212. Orellana, D.I., Quintanilla, R.A., Gonzalez-Billault, C. and Maccioni, R.B., 2005, Role of the JAKs/STATs pathway in the intracellular calcium changes induced by interleukin-6 in hippocampal neurons. Neurotox. Res. 8: 295.PubMedGoogle Scholar
  213. Ozinsky, A., Underhill, D.M., Fontenot, J.D., Hajjar, A.M., Smith, K.D., Wilson, C.B., Schroeder, L. and Aderem, A., 2000, The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. USA 97: 13766.PubMedGoogle Scholar
  214. Park, S.M., Schickel, R. and Peter, M.E., 2005, Nonapoptotic functions of FADD-binding death receptors and their signaling molecules. Curr. Opin. Cell Biol. 17: 610.PubMedGoogle Scholar
  215. Patel, H.C., Ross, F.M., Heenan, L.E., Davies, R.E., Rothwell, N.J. and Allan, S.M., 2006, Neurodegenerative actions of interleukin-1 in the rat brain are mediated through increases in seizure activity. J. Neurosci. Res. 83: 385.PubMedGoogle Scholar
  216. Pearson, V.L., Rothwell, N.J. and Toulmond, S., 1999, Excitotoxic brain damage in the rat induces interleukin-1beta protein in microglia and astrocytes: correlation with the progression of cell death. Glia 25: 311.PubMedGoogle Scholar
  217. Perea, G. and Araque, A., 2005, Glial calcium signaling and neuron-glia communication. Cell Calcium 38: 375.PubMedGoogle Scholar
  218. Perea, G. and Araque, A., 2006, Synaptic information processing by astrocytes. J. Physiol. Paris 99: 92.PubMedGoogle Scholar
  219. Perregaux, D.G. and Gabel, C.A., 1998, Post-translational processing of murine IL-1: evidence that ATP-induced release of IL-1 alpha and IL-1 beta occurs via a similar mechanism. J. Immunol. 160: 2469.PubMedGoogle Scholar
  220. Perry, V.H., 2004, The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav. Immun. 18: 407.PubMedGoogle Scholar
  221. Perry, V.H. and Gordon, S., 1991, Macrophages and the nervous system. Int. Rev. Cytol. 125: 203.PubMedGoogle Scholar
  222. Persson, M., Brantefjord, M., Hansson, E. and Ronnback, L., 2005, Lipopolysaccharide increases microglial GLT-1 expression and glutamate uptake capacity in vitro by a mechanism dependent on TNF-alpha. Glia 51: 111.PubMedGoogle Scholar
  223. Pettus, B.J., Chalfant, C.E. and Hannun, Y.A., 2002, Ceramide in apoptosis: an overview and current perspectives. Biochim. Biophy. Acta 1585: 114.Google Scholar
  224. Piehl, F. and Lidman, O., 2001, Neuroinflammation in the rat-CNS cells and their role in the regulation of immune reactions. Immunol. Rev. 184: 212.PubMedGoogle Scholar
  225. Pinteaux, E., Parker, L.C., Rothwell, N.J. and Luheshi, G.N., 2002, Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells. J. Neurochem. 83: 754.PubMedGoogle Scholar
  226. Pinteaux, E., Rothwell, N.J. and Boutin, H., 2006, Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia. Glia 53: 551.PubMedGoogle Scholar
  227. Pradillo, J.M., Hurtado, O., Romera, C., Cardenas, A., Fernandez-Tome, P., Alonso-Escolano, D., Lorenzo, P., Moro, M.A. and Lizasoain, I., 2006, TNFR1 mediates increased neuronal membrane EAAT3 expression after in vivo cerebral ischemic preconditioning. Neuroscience 138: 1171.PubMedGoogle Scholar
  228. Pringle, A.K., Niyadurupola, N., Johns, P., Anthoni, D.C. and Iannotti, F., 2001, Interleukin-1 beta exacerbates hypoxia-induced neuronal damage, but attenuates toxicity produced by simulated ischaemia and excitotoxicity in rat organotypic hippocampal slice cultures. Neurosci. Lett. 305: 29.PubMedGoogle Scholar
  229. Proudfoot, A.E., 2002, Chemokine receptors: multifaceted therapeutic targets. Nat. Rev. Immunol. 2: 106.PubMedGoogle Scholar
  230. Qian, Y., Commane, M., Ninomiya-Tsuji, J., Matsumoto, K. and Li, X., 2001, IRAK-mediated translocation of TRAF6 and TAB2 in the interleukin-1-induced activation of NFkappa B. J. Biol. Chem. 276: 41661.PubMedGoogle Scholar
  231. Raivich, G., Jones, L.L., Kloss, C.U., Werner, A., Neumann, H. and Kreutzberg, G.W., 1998, Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration. J. Neurosci. 18: 5804.PubMedGoogle Scholar
  232. Rappert, A., Bechmann, I., Pivneva, T., Mahlo, J., Biber, K., Nolte, C., Kovac, A.D., Gerard, C., Boddeke, H.W., Nitsch, R. and Kettenmann, H., 2004, CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J. Neurosci. 24: 8500.PubMedGoogle Scholar
  233. Rivest, S., 2003, Molecular insights on the cerebral innate immune system. Brain Behav. Immun. 17: 13.Google Scholar
  234. Rossi, D. and Zlotnik, A., 2000, The biology of chemokines and their receptors. Annu. Rev. Immunol. 18: 217.PubMedGoogle Scholar
  235. Rothwell, N.J., 1999, Annual review prize lecture cytokines - killers in the brain? J. Physiol. 514: 3.PubMedGoogle Scholar
  236. Rothwell, N.J. and Luheshi, G.N., 2000, Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23: 618.PubMedGoogle Scholar
  237. Sairanen, T.R., Lindsberg, P.J., Brenner, M., Carpen, O. and Siren, A., 2001, Differential cellular expression of tumor necrosis factor-alpha and Type I tumor necrosis factor receptor after transient global forebrain ischemia. J. Neurol. Sci. 186: 87.PubMedGoogle Scholar
  238. Sanz, J.M. and Di Virgilio, F., 2000, Kinetics and mechanism of ATP-dependent IL-1 beta release from microglial cells. J. Immunol. 164: 4893.PubMedGoogle Scholar
  239. Sayyah, M., Beheshti, S., Shokrgozar, M.A., Eslami-far, A., Deljoo, Z., Khabiri, A.R. and Haeri Rohani, A., 2005, Antiepileptogenic and anticonvulsant activity of interleukin-1 beta in amygdala-kindled rats. Exp. Neurol. 191: 145.PubMedGoogle Scholar
  240. Schulz, M. and Engelhardt, B., 2005, The circumventricular organs participate in the immunopathogenesis of experimental autoimmune encephalomyelitis. Cerebrospinal Fluid Res. 2: 8.PubMedGoogle Scholar
  241. Schwartz, M., Moalem, G., Leibowitz-Amit, R. and Cohen, I.R., 1999, Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci. 22: 295.PubMedGoogle Scholar
  242. Schwartz, M., Butovsky, O., Bruck, W. and Hanisch, U.K., 2006, Microglial phenotype: is the commitment reversible? Trends Neurosci. 29: 68.PubMedGoogle Scholar
  243. Serou, M.J., DeCoster, M.A. and Bazan, N.G., 1999, Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression. J. Neurosci. Res. 58: 593.PubMedGoogle Scholar
  244. Shandra, A.A., Godlevsky, L.S., Vastyanov, R.S., Oleinik, A.A., Konovalenko, V.L., Rapoport, E.N. and Korobka, N.N., 2002, The role of TNF-alpha in amygdala kindled rats. Neurosci. Res. 42: 147.PubMedGoogle Scholar
  245. Sheng, W.S., Hu, S., Ni, H.T., Rowen, T.N., Lokensgard, J.R. and Peterson, P.K., 2005, TNF-alpha-induced chemokine production and apoptosis in human neural precursor cells. J. Leukoc. Biol. 78: 1233.PubMedGoogle Scholar
  246. Shim, J.H., Xiao, C., Paschal, A.E., Bailey, S.T., Rao, P., Hayden, M.S., Lee, K.Y., Bussey, C., Steckel, M., Tanaka, N., Yamada, G., Akira, S., Matsumoto, K. and Ghosh, S., 2005, TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19: 2668.PubMedGoogle Scholar
  247. Shinoda, S., Skradski, S.L., Araki, T., Schindler, C.K., Meller, R., Lan, J.Q., Taki, W., Simon, R.P. and Henshall, D.C., 2003, Formation of a tumour necrosis factor receptor 1 molecular scaffolding complex and activation of apoptosis signal-regulating kinase 1 during seizure-induced neuronal death. Eur. J. Neurosci. 17: 2065.PubMedGoogle Scholar
  248. Shrikant, P. and Benveniste, E.N., 1996, The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation. J. Immunol. 157: 1819.PubMedGoogle Scholar
  249. Simard, A.R. and Rivest, S., 2005, Do pathogen exposure and innate immunity cause brain diseases? Neurol. Res. 27: 717.PubMedGoogle Scholar
  250. Sims, J.E., March, C.J., Cosman, D., Widmer, M.B., MacDonald, H.R., McMahan, C.J., Grubin, C.E., Wignall, J.M., Jackson, J.L., Call, S.M., et al., 1988, DNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241: 585PubMedGoogle Scholar
  251. Sims, J.E., Gayle, M.A., Slack, J.L., Alderson, M.R., Bird, T.A., Giri, J.G., Colotta, F., Re, F., Mantovani, A., Shanebeck, K., et al., 1993, Interleukin 1 signaling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. USA 90: 6155.PubMedGoogle Scholar
  252. Sofroniew, M.V., 2005, Reactive astrocytes in neural repair and protection. Neuroscientist 11: 400.PubMedGoogle Scholar
  253. Solle, M., Labasi, J., Perregaux, D.G., Stam, E., Petrushova, N., Koller, B.H., Griffiths, R.J and Gabel, C.A., 2001, Altered cytokine production in mice lacking P2X(7) receptors. J. Biol. Chem. 276: 125.PubMedGoogle Scholar
  254. Srinivasan, D., Yen, J.H., Joseph, D.J. and Friedman, W., 2004, Cell type-specific interleukin-1beta signaling in the CNS. J. Neurosci. 24: 6482.PubMedGoogle Scholar
  255. Sriram, K., Matheson, J.M., Benkovic, S.A., Miller, D.B., Luster, M.I. and O'Callaghan, J.P., 2002, Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease. FASEB J. 16: 1474.PubMedGoogle Scholar
  256. Streit, W.J., 2002, Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40: 133.PubMedGoogle Scholar
  257. Streit, W.J., Walter, S.A. and Pennell, N.A., 1999, Reactive microgliosis. Prog. Neurobiol. 57: 563.PubMedGoogle Scholar
  258. Strijbos, P.J. and Rothwell, N.J., 1995, Interleukin-1 beta attenuates excitatory amino acid-induced neuro-degeneration in vitro: involvement of nerve growth factor. J. Neurosci. 15: 3468.PubMedGoogle Scholar
  259. Suzuki, T., Hide, I., Ido, K., Kohsaka, S., Inoue, K. and Nakata, Y., 2004, Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. J. Neurosci. 24: 1.PubMedGoogle Scholar
  260. Sylte, M.J., Kuckleburg, C.J., Inzana, T.J., Bertics, P.J. and Czuprynski, C.J., 2005, Stimulation of P2X receptors enhances lipooligosaccharide-mediated apoptosis of endothelial cells. J. Leukoc. Biol. 77: 958.PubMedGoogle Scholar
  261. Takada, H., Chen, N.J., Mirtsos, C., Suzuki, S., Suzuki, N., Wakeham, A., Mak, T.W. and Yeh, W.C., 2003, Role of SODD in regulation of tumor necrosis factor responses. Mol. Cell Biol. 23: 4026.PubMedGoogle Scholar
  262. Takaesu, G., Kishida, S., Hiyama, A., Yamaguchi, K., Shibuya, H., Irie, K., Ninomiya-Tsuji, J. and Matsumoto, K., 2000, TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol. Cell. 5: 649.PubMedGoogle Scholar
  263. Takaesu, G., Ninomiya-Tsuji, J., Kishida, S., Li, X., Stark, G.R. and Matsumoto, K., 2001, Interleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathway. Mol. Cell Biol. 21: 2475.PubMedGoogle Scholar
  264. Takao, T., Tracey, D.E., Mitchell, W.M. and De Souza, E.B., 1990, Interleukin-1 receptors in mouse brain: characterization and neuronal localization. Endocrinology 127: 3070.PubMedGoogle Scholar
  265. Takeuchi, H., Jin, S., Wang, J., Zhang, G., Kawanokuchi, J., Kuno, R., Sonobe, Y., Mizuno, T. and Suzumura, A., 2006, Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J. Biol. Chem. 281: 21362.PubMedGoogle Scholar
  266. Tamatani, M., Che, Y.H., Matsuzaki, H., Ogawa, S., Okado, H., Miyake, S., Mizuno, T. and Tohyama, M., 1999, Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J. Biol. Chem. 274: 8531.PubMedGoogle Scholar
  267. Tartaglia, L.A., Ayres, T.M., Wong, G.H. and Goeddel, D.V., 1993, A novel domain within the 55 kd TNF receptor signals cell death. Cell 74: 845.PubMedGoogle Scholar
  268. Taylor, D.L., Jones, F., Kubota, E.S. and Pocock, J.M., 2005, Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand. J. Neurosci. 25: 2952.PubMedGoogle Scholar
  269. Thakar, J., Schleinkofer, K., Borner, C. and Dandekar, T., 2006, RIP death domain structural interactions implicated in TNF-mediated proliferation and survival. Proteins 63: 413.PubMedGoogle Scholar
  270. Thanos, D. and Maniatis, T., 1995, NF-kappa B: a lesson in family values. Cell 80: 529.PubMedGoogle Scholar
  271. Thomas, W.E., 1999, Brain macrophages: on the role of pericytes and perivascular cells. Brain Res. Brain Res. Rev. 31: 42.PubMedGoogle Scholar
  272. Thommesen, L. and Laegreid, A., 2005, Distinct differences between TNF receptor 1- and TNF receptor 2-mediated activation of NFkappaB. J. Biochem. Mol. Biol. 38: 281.PubMedGoogle Scholar
  273. Thompson, C., Gary, D., Mattson, M., Mackenzie, A. and Robertson, G.S., 2004, Kainic acid-induced naip expression in the hippocampus is blocked in mice lacking TNF receptors. Brain Res. Mol. Brain Res. 123: 126.PubMedGoogle Scholar
  274. Thornberry, N.A., Bull, H.G., Calaycay, J.R., Chapman, K.T., Howard, A.D., Kostura, M.J., Miller, D.K., Molineaux, S.M., Weidner, J.R., Aunins, J., et al., 1992, A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356: 768.PubMedGoogle Scholar
  275. Traenckner, E.B., Wilk, S. and Baeuerle, P.A., 1994, A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J. 13: 5433.PubMedGoogle Scholar
  276. Traenckner, E.B., Pahl, H.L., Henkel, T., Schmidt, K.N., Wilk, S. and Baeuerle, P.A., 1995, Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J. 14: 2876.PubMedGoogle Scholar
  277. Turrin, N.P. and Rivest, S., 2006, Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity. J. Neurosci. 26: 143.PubMedGoogle Scholar
  278. Ubogu, E.E., Cossoy, M.B. and Ransohoff, R.M., 2006, The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol. Sci. 27: 48.Google Scholar
  279. Vassalli, P., 1992, The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10: 411.PubMedGoogle Scholar
  280. Verma, I.M., Stevenson, J.K., Schwarz, E.M., Van Antwerp, D. and Miyamoto, S., 1995, Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 9: 2723.PubMedGoogle Scholar
  281. Vezzani, A., Conti, M., De Luigi, A., Ravizza, T., Moneta, D., Marchesi, F. and De Simoni, M.G., 1999, Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J. Neurosci. 19: 5054.PubMedGoogle Scholar
  282. Vezzani, A., Moneta, D., Conti, M., Richichi, C., Ravizza, T., De Luigi, A., De Simoni, M.G., Sperk, G., Andell-Jonsson, S., Lundkvist, J., Iverfeldt, K. and Bartfai, T., 2000, Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc. Natl. Acad. Sci. USA 97: 11534.PubMedGoogle Scholar
  283. Vilček, J., 2003, The Cytokine Handbook. Elsevier Science, London, pp. 3-18.Google Scholar
  284. Vilz, T.O., Moepps, B., Engele, J., Molly, S., Littman, D.R. and Schilling, K., 2005, The SDF-1/CXCR4 pathway and the development of the cerebellar system. Eur. J. Neurosci. 22: 1831.PubMedGoogle Scholar
  285. Viviani, B., Bartesaghi, S., Gardoni, F., Vezzani, A., Behrens, M.M., Bartfai, T., Binaglia, M., Corsini, E., Di Luca, M., Galli, C.L. and Marinovich, M., 2003, Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 23: 8692.PubMedGoogle Scholar
  286. Wajant, H., Pfizenmaier, K. and Scheurich, P., 2003, Tumor necrosis factor signaling. Cell Death Differ. 10: 45.PubMedGoogle Scholar
  287. Wallach, D., Engelmann, H., Nophar, Y., Aderka, D., Kemper, O., Hornik, V., Holtmann, H. and Brakebusch, C., 1991, Soluble and cell surface receptors for tumor necrosis factor. Agents Actions Suppl. 35: 51.PubMedGoogle Scholar
  288. Wang, C.X. and Shuaib, A., 2002, Involvement of inflammatory cytokines in central nervous injury. Prog. Neurobiol. 67: 161.PubMedGoogle Scholar
  289. Wang, X., Barone, F.C., Aiyar, N.V. and Feuerstein, G.Z., 1997, Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats. Stroke 28: 155.PubMedGoogle Scholar
  290. Wang, C.Y., Mayo, M.W., Korneluk, R.G., Goeddel, D.V. and Baldwin, A.S. Jr., 1998, NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281: 1680.PubMedGoogle Scholar
  291. Wang, X., Chen, S., Ma, G., Ye, M. and Lu, G., 2005a, Involvement of proinflammatory factors, apoptosis, caspase-3 activation and Ca2+ disturbance in microglia activation-mediated dopaminergic cell degeneration. Mech. Ageing Dev. 126: 1241.PubMedGoogle Scholar
  292. Wang, X.J., Kong, K.M., Qi, W.L., Ye, W.L. and Song, P.S., 2005b, Interleukin-1 beta induction of neuron apoptosis depends on p38 mitogen-activated protein kinase activity after spinal cord injury. Acta Pharmacol. Sin. 26: 934.PubMedGoogle Scholar
  293. Wei, R. and Jonakait, G.M., 1999, Neurotrophins and the anti-inflammatory agents interleukin-4 (IL-4), IL-10, IL-11 and transforming growth factor-beta1 (TGF-beta1) down-regulate T cell costimulatory molecules B7 and CD40 on cultured rat microglia. J. Neuroimmunol. 95: 8.PubMedGoogle Scholar
  294. Wesche, H., Korherr, C., Kracht, M., Falk, W., Resch, K. and Martin, M.U., 1997, The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J. Biol. Chem. 272: 7727.PubMedGoogle Scholar
  295. Wiegmann, K., Schutze, S., Machleidt, T., Witte, D. and Kronke, M., 1994, Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78: 1005.PubMedGoogle Scholar
  296. Wilde, G.J., Pringle, A.K., Sundstrom, L.E., Mann, D.A. and Iannoyyi, F., 2000, Attenuation and augmentation of ischaemia-related neuronal damage by tumor necrosis factor-alpha in vitro. Eur. J. Neurosci. 12: 3863.PubMedGoogle Scholar
  297. Williams, K., Alvarez, X. and Lackner, A.A., 2001, Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system. Glia 36: 156.PubMedGoogle Scholar
  298. Windhagen, A., Newcombe, J., Dangond, F., Strand, C., Woodroofe, M.N., Cuzner, M.L. and Hafler, D.A., 1995, Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182: 1985.PubMedGoogle Scholar
  299. Wong, D., Prameya, R. and Dorovini-Zis, K., 1999, In vitro adhesion and migration of T lymphocytes across monolayers of human brain microvessel endothelial cells: regulation by ICAM-1, VCAM-1, E-selectin and PECAM-1. J. Neuropathol. Exp. Neurol. 58: 138.PubMedGoogle Scholar
  300. Wright, S.D., 1999, Toll, a new piece in the puzzle of innate immunity. J. Exp. Med. 189: 605.PubMedGoogle Scholar
  301. Xia, Y., Yamagata, K. and Krukoff, T.L., 2006, Differential expression of the CD14/TLR4 complex and inflammatory signaling molecules following i.c.v. administration of LPS. Brain Res. [Epub ahead of print].Google Scholar
  302. Yabuuchi, K., Minami, M., Katsumata, S. and Satoh, M., 1994, Localization of type I interleukin-1 receptor mRNA in the rat brain. Brain Res. Mol. Brain Res. 27: 2736.Google Scholar
  303. Yamin, T.T. and Miller, D.K., 1997, The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation. J. Biol. Chem. 272: 21540.PubMedGoogle Scholar
  304. Yang, L., Lindholm, K., Konishi, Y., Li, R. and Shen, Y., 2002, Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways. J. Neurosci. 22: 3025.PubMedGoogle Scholar
  305. Ye, Z.C. and Sontheimer, H., 1996, Cytokine modulation of glial glutamate uptake: a possible involvement of nitric oxide. Neuroreport 7: 2181.PubMedCrossRefGoogle Scholar
  306. Yeager, M.P., DeLeo, J.A., Hoopes, P.J., Hartov, A., Hildebrandt, L. and Hickey, W.F., 2000, Trauma and inflammation modulate lymphocyte localization in vivo: quantitation of tissue entry and retention using indium-111-labeled lymphocytes. Crit. Care Med. 28: 1477.PubMedGoogle Scholar
  307. Yeh, W.C., Shahinian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., de la Pompa, J.L., Ferrick, D., Hum, B., Iscove, N., Ohashi, P., Rothe, M., Goeddel, D.V. and Mak, T.W., 1997, Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7: 715.PubMedGoogle Scholar
  308. Yu, Z., Cheng, G., Wen, X., Wu, G.D., Lee, W.T. and Pleasure, D., 2002, Tumor necrosis factor alpha increases neuronal vulnerability to excitotoxic necrosis by inducing expression of the AMPA-glutamate receptor subunit GluR1 via an acid sphingomyelinase- and NF-kappaB-dependent mechanism. Neurobiol. Dis. 11: 199.PubMedGoogle Scholar
  309. Yuhas, Y., Weizman, A. and Ashkenazi, S., 2003, Bidirectional concentration-dependent effects of tumor necrosis factor alpha in Shigella dysenteriae-related seizures. Infect. Immun. 71: 2288.PubMedGoogle Scholar
  310. Yuhas, Y., Shulman, L., Weizman, A., Kaminsky, E., Vanichkin, A. and Ashkenazi, S., 1999, Involvement of tumor necrosis factor alpha and interleukin-1beta in enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae. Infect. Immun. 67: 1455.PubMedGoogle Scholar
  311. Zandi, E., Rothwarf, D.M., Delhase, M., Hayakawa, M. and Karin, M., 1997, The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91: 243.PubMedGoogle Scholar
  312. Zhang, G. and Ghosh, S., 2002, Negative regulation of toll-like receptor-mediated signaling by Tollip. J. Biol. Chem. 277: 7059.PubMedGoogle Scholar
  313. Zhang, J. and Rivest, S., 2003, Is survival possible without arachidonate metabolites in the brain during systemic infection? News Physiol. Sci. 18: 137.PubMedGoogle Scholar
  314. Zheng, L., Bidere, N., Staudt, D., Cubre, A., Orenstein, J., Chan, F.K. and Lenardo, M., 2006, Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1. Mol. Cell Biol. 26: 3505.PubMedGoogle Scholar
  315. Zhou, C., Tai, C., Ye, H.H., Ren, X., Chen, J.G., Wang, S.Q. and Chai, Z., 2006, Interleukin-1beta downregulates the L-type Ca2+ channel activity by depressing the expression of channel protein in cortical neurons. J. Cell Physiol. 206: 799.PubMedGoogle Scholar
  316. Zimmer, J., Kristensen, B.W., Jakobsen, B. and Noraberg, J., 2000, Excitatory amino acid neurotoxicity and modulation of glutamate receptor expression in organotypic brain slice cultures. Amino Acids 19: 7.PubMedGoogle Scholar
  317. Zlotnik, A. and Yoshie, O., 2000, Chemokines: a new classification system and their role in immunity. Immunity 12: 121.PubMedGoogle Scholar
  318. Zou, J.Y. and Crews, F.T., 2005, TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. Brain Res. 1034: 11.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • João O. Malva
    • 1
  • Liliana Bernardino
  1. 1.Center for Neuroscience and Cell Biology, Institute of Biochemistry, Faculty of MedicineUniversity of CoimbraPortugal

Personalised recommendations